Theratechnologies (TSX:TH) announced that it has received feedback from the FDA regarding the timeline to review tesamorelin’s New Drug Application for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy. The FDA has indicated that the review is progressing well. The Company now expects to have an official response in the fourth quarter of 2010. Theratechnologies and the Agency continue the positive and constructive dialogue regarding the regulatory process for tesamorelin.
The coming months will be entertaining in the obesity market with 3 companies fighting to get FDA approval.
The pain coursing through American families is all too real and no one seems to know what to do about it. A rigorous new analysis for the Rockefeller Foundation shows that Americans are more economically insecure now than they have been in a quarter of a century, and the trend lines suggest that things will [...]
Los Zetas drug cartel seizes 2 U.S. ranches in Texas
July 24, 11:18 AMSan Diego County Political Buzz ExaminerKimberly DvorakPrevious
215 comments Subscribe
Subscribe
Get alerts when there is a new article from the San Diego County Political Buzz Examiner. Read Examiner.com’s terms of use. Email Address
Include other special offers from Examiner.com
Terms of Use
Drug smugglers walking north into American [...]
1) Districts’ pension contributions cut (Pennsylvania)
“Pennsylvania school districts got some breathing room in their budgets on Friday by having their contribution rate to employees’ pension system cut by a third.
The Public School Employees’ Retirement System voted 12-2 to cut the employers’ contribution rate that taxpayers pay to 5.64 percent of [...]
Annualized New Home sales
1996 700,000
1998 800,000
2000 875,000
2002 900,000
2004 1,190,000
2006 1,300,000
2008 550,000
2010 330,000
If it wasn’t for a lack of context there would be no news.
From calculatedriskblog:
Ignore all the month to previous month comparisons. May was revised down sharply and that makes the increase look significant. Here is the bottom line: this was [...]
If you thought volatility in stocks was beyond ridiculous, we hope you have been keeping an eye out on what happens to the US economy when the central planning bureau takes over. Case in point: the Dallas Fed Manufacturing index of General Business Activity was just released, and it is a [...]
ePad running Android,1 GHz processor and usb connection, even looks very much like the iPad in design as well as the same size for $250:
http://animetrader.co.uk/blog/new-products/mobile/an-ipad-clone-running-android-with-the-full-10-inches/
http://www.shanzai.com/index.php?option=com_content&task=view&id=1484&Itemid=76
Zenithink 10.2in touch screen ePad, Android based, 16GB flash storage, up to 7 hours battery use (wi fi off)1080p:
http://besttabletreview.com/zenithink-ipad-clone-impressive/
http://wiipad.us/product.php?id_product=11
New tablet pc that looks quite similar to iPad, from Pioneer Computers, Australia’s [...]
This day has the potential for some downside. On a short-term basis, we are a bit overbought. The reason I say we have the “potential” for some downside today, however, is that the overbought condition is not gargantuan. The market was pushed higher on Friday afternoon than it had a right to be. It is [...]
FT:
The commission will not back down from demands for information Goldman’s executives have maintained they do not track, Phil Angelides told the Financial Times.
“We have a deep level of questioning about whether we’re getting the straight scoop here and whether Goldman is working with us on information [...]
